This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Duran, M., Beemer, F.A., v. d. Heiden, C., et al., 1978, Combined deficiency of xanthine oxidase and sulphite oxidase: a defect of molybdenum metabolism or transport? J. Inher. Metab. Dis. 1: 175–178.
Wilson, J.M., Young, A.B., and Kelley, W.N., 1983, Hypoxanthine-guanine phosphoribosyltransferase deficiency. The molecular basis of the clinical syndromes. New Engl. J. Med. 309: 900–910.
Hogan, B., 1987, Lesch-Nyhan syndrome. Engineering mutant mice. Nature 326:240–241.
Sperling, O., Boer, P., Persky-Brosh, S., et al., 1972, Altered kinetic property of erythrocyte phosphoribosylpyrophosphate synthetase in excessive purine production. Rev. Europ. Etudes Clin. Biol. 17: 703–706.
Becker, M.A., Smith, P.R., Taylor W., et al., 1995, The genetic and functional basis of purine nucleotide feedback-resistant phosphoribosylpyrophosphate synthetase superactivity. J. Clin. Invest. 96: 2133–2141.
Giblett, E.R., Anderson, J.E., Cohen, F., et al., 1972, Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity. Lancet 2: 1067–1069.
Carson, D.A., Wasson, D.B., and Beutler, E., 1984, Antileukemic and immunosuppressive activity of 2-chloro-2′-deoxyadenosine. Proc. Natl. Acad. Sci. USA 81: 2232–2236.
Hershfield, M.S., Buckley, R.H., Greenberg, M.L., et al., 1987, Treatment of adenosine deaminase deficiency with polyethylene glycol-modified adenosine deaminase. New Engl. J. Med. 316: 589–596.
Blaese, R.M., Culver, K. W., Miller, A.D., et al., 1995, T lymphocyte-directed gene therapy for ADA-SCID: initial trial results after 4 years. Science 270: 475–480.
Van Acker, K.J., Simmonds, H.A., Potter, C., and Cameron, J.S., 1977, Complete deficiency of adenine phosphoribosyltransferase. Report of a family. New Engl. J. Med. 297: 127–132, 1977.
Kamatani, N., Terai, C., Kuroshima, S., et al., 1987, Genetic and clinical studies on 19 families with adenine phosphoribosyltransferase deficiencies. Hum. Genet. 75: 163–168.
Simmonds, H.A., Warren, D.J., Cameron, J.S., et al., 1980, Familial gout and renal failure in young women. Clin. Nephrol. 14: 176–182.
Fishbein, W.N., Armbrustmacher, V.W., and Griffin, J.L., 1978, Myoadenylate deaminase deficiency: a new disease of muscle. Science 200: 545–548.
Morisaki, T., Gross, M., Morisaki. H., et al., 1992, Molecular basis of AMP deaminase deficiency in skeletal muscle. Proc. Natl. Acad. Sci. USA 89: 6457–6461.
Loh, E., Rebbeck, T.R., Mahoney, P.D., et al., 1999, Common variant in AMPD1 gene predicts improved clinical outcome in patients with heart failure. Circulation 99: 1422–1425.
Van Gennip, A.H., Abeling, N.G.G.M., Vreken P., and van Kuilenburg, A.B.P., 1997, Inborn errors of pyrimidine degradation: clinical, biochemical and molecular aspects. J. Inher. Metab. Dis. 20: 203–213.
Lennard, L., Van Loon, J.A., and Weinshilboum, R.M., 1989, Pharmacogenetics of acute azathioprine toxicity: relationship to thiopurine methyltransferase genetic polymorphism. Clin. Pharmacol. Ther. 46: 149–154.
Van den Berghe, G., Vincent, M.F., and Jaeken, J., 1997, Inborn errors of the purine nucleotide cycle: adenylosuccinase deficiency. J. Inher. Metab. Dis. 20: 193–202.
Assmann, B., Göhlig-Ratmann, G., Bräutigam, C., et al., 1998, Presumptive ureidopropionase deficiency as a new defect in pyrimidine catabolism found with in vitro H-NMR spectroscopy. J. Inher. Metab. Dis. 21: Suppl. 2, 1.
Wiesner, J.B., Ugarkar, B.G., Castellino, A.J., et al., 1999, Adenosine kinase inhibitors as a novel approach to anticonvulsant therapy. J. Pharmacol. Exp. Ther. 289: 1669–1677.
Erion, M.D., Kasibhatla, S.R., Bookser, B.C., et al., 1999, Discovery of AMP mimetics that exhibit high inhibitory potency and specificity for AMP deaminase. J. Am. Chem. Soc. 121: 308–319.
Vincent, M.F., Erion, M.D., Gruber, H.E., and Van den Berghe, G., 1996, Hypoglycaemic effect of AICAriboside in mice. Diabetologia 39: 1148–1155.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Kluwer Academic Publishers
About this chapter
Cite this chapter
Van Den Berghe, G. (2002). Purine and Pyrimidine Metabolism Between Millennia: What has been Accomplished, What has to be Done?. In: Zoref-Shani, E., Sperling, O. (eds) Purine and Pyrimidine Metabolism in Man X. Advances in Experimental Medicine and Biology, vol 486. Springer, Boston, MA. https://doi.org/10.1007/0-306-46843-3_1
Download citation
DOI: https://doi.org/10.1007/0-306-46843-3_1
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-46515-4
Online ISBN: 978-0-306-46843-8
eBook Packages: Springer Book Archive